phorbol 12,13-dibutyrate has been researched along with 12-deoxyphorbolphenylacetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, G; Brooks, SF | 1 |
| Haskard, DO; Mason, JC; Sugars, K; Yarwood, H | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and 12-deoxyphorbolphenylacetate
| Article | Year |
|---|---|
Both tumour-promoting and non-promoting phorbol esters inhibit [125I]EGF binding and stimulate the phosphorylation of an 80 kd protein kinase C substrate protein in intact quiescent swiss 3T3 cells.
Topics: Animals; Cell Line; Epidermal Growth Factor; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phosphoproteins; Phosphorylation; Protein Kinase C | 1990 |
Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation.
Topics: Cell Adhesion Molecules; Cell Division; Cells, Cultured; Cycloheximide; E-Selectin; Endothelium, Vascular; Enzyme Activation; Humans; Kinetics; Microcirculation; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; RNA, Messenger; Skin; Thy-1 Antigens; Transcription, Genetic; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 1997 |